OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL

Autor: Linhares, Yuliya, Freytes, Cesar O., Cherry, Mohamad, Bachier, Carlos, Maris, Michael, Hoda, Daanish, Varela, Juan C., Bellomo, Courtney, Cross, Scott, Essell, James, Fanning, Suzanne, Terebelo, Howard, Yimer, Habte, Courtright, Jay, Sharman, Jeff P., Kostic, Ana, Vedal, Min, Ogasawara, Ken, Avilion, Ariel, Espinola, Ricardo, Yuan, Brenda, Mattar, Bassam
Zdroj: In Blood Advances 10 December 2024 8(23):6114-6126
Databáze: ScienceDirect